Incretin mimetics (GLP-1 receptor agonists) directly mimic the action of the hormone GLP-1, whilst DPP-4 inhibitors (gliptins) prolong the activity of the body's own incretin hormones
Pivotal clinical trials in continuous ketone monitoring, akin to currently available continuous glucose monitoring, are taking place in 2023 [53]
Sometimes, skin or blood tests may be used to identify underlying causes
Denial rates appear to be easing as the clinical evidence base strengthens
Patients may start using a product or service while they are on the prescription, and then maintain use after theyve stopped, ideally slowing or preventing the weight gain that has been associated with the end of a GLP-1 prescription
This is the foundational glutathione supplement mechanism that has been validated in 90+ clinical studies, protected by 79 international patents, and listed in both the US Physicians Desk Reference and Canadas Compendium of Pharmaceuticals and Specialties